Mass General researchers are testing the psychedelic compound psilocybin as a therapeutic for treatment-resistant depression.
Mass General researchers are testing the psychedelic compound psilocybin as a therapeutic for treatment-resistant depression.
Copyright 2024 | Mass General Research Institute | Disclaimer